Two approved antifibrotic IPF therapies, Ofev (nintedanib) and Esbriet (pirfenidone), were available during the study period, and participants were ...
Source link

Two approved antifibrotic IPF therapies, Ofev (nintedanib) and Esbriet (pirfenidone), were available during the study period, and participants were ...
Source link